You are here: Home > ABOUT US > News and Events > New Clinical Study Results



Drucker Labs

1600 Capital Ave. #100, Plano, TX 75074

www.druckerlabs.com


Phone: 888-881-2344


PRESS RELEASE


 


 


DRUCKER LABS PUBLISHES NEW CLINICAL STUDY RESULTS


Plano, TX June 22, 2009 – Drucker Labs recently commissioned a 30-day Peer-Reviewed Double-Blind Placebo FDA Gold Standard Clinical Study that revealed outstanding results for the product intraMAX®.  The purpose of this study was to evaluate an all-natural, all-in-one essential nutrient supplement product, intraMAX, with respect to helping normalize and improve cellular functions.


 


The study was a 30-day, 125-person study with subjects drawn from a large population of people with various cellular imbalances.  The subjects were randomized into two groups.  The placebo group was made up of 75-subjects.  Subjects in both Group A (live product group) and Group B (placebo group) were provided and instructed to take one ounce of product twice daily on an empty stomach with a full glass of purified water.  Instructions also included: no eating or drinking within at least one-half hour of taking the product and no pharmaceuticals (unless it was a medical emergency) or nutraceuticals for at least two hours after consuming the product.


 


The Gold Standard Clinical Study Results showed that intraMAX subjects experienced significant improvement in energy levels and energy production. intraMAX significantly improved pH levels, which allowed other ingredients to be identified and utilized by the body more efficiently. intraMAX reduced cellular toxicity and build-up of cellular toxins, improved movement of all the fluids in the body, and helped reduce "free-radical" damage and aging significantly.


Drucker Labs is the leading manufacturer of Carbon-Bonded Liquid Nutritional Supplements.  For further information, please call 888.881.2344.